As a proof-of-principle we chose to analyze sorted NCAM+EpCAM−, NCAM+EpCAM+ (containing putative MM stem- and MM-derived progenitor cells, respectively) in comparison with NCAM− HFK cell populations as NCAM and EpCAM are important surface markers for our characterization system. The gene discussed is EPCAM; the disease is Miyoshi myopathy.